| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.019 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |